Form 4 for VRTX Vertex Pharmaceuticals
Accepted 2023-11-08 00:00:00 ET · period of report 2023-11-06 · accession 0000875320-23-000033 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-11-08 | 2023-11-06 | VRTX | SACHS BRUCE I | Dir | S - Sale+OE | $385.00 | -11.2K | 40.0K | -22% | -$4.33M |
| D | 2023-11-08 | 2023-11-06 | VRTX | SACHS BRUCE I | Dir | M - OptEx | $127.54 | +11.2K | 51.2K | +28% | +$1.43M |
| D | 2023-11-08 | 2023-11-06 | VRTX | SACHS BRUCE I | Dir | M - OptEx | $0.00 | -11.2K | 11.2K | -50% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-11-06 | S | D | 11,250 | $385.00 | 40,000 | D | — | — | (F3) Open market sales reported on this line occurred at a weighted average price of $385.00 (range $385.00 to $385.02). (F2) Mr. Sachs undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. |
| 2 | Common | Common Stock | 2023-11-06 | M | A | 11,250 | $127.54 | 51,250 | D | — | — | |
| 3 | Derivative | Stock Option (Right to Buy) | 2023-11-06 | M | D | 11,250 | $0.00 | 11,250 | D | $127.54 · — to 2025-05-31 | 11,250 Common Stock | (F4) Fully vested. |